Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I-III Non-small Cell Lung Cancer”

245 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 245 results

Testing effectiveness (Phase 2)Study completedNCT00227539
What this trial is testing

Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Washington 25
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Testing effectiveness (Phase 2)Study completedNCT00178256
What this trial is testing

Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
University of Rochester 41
Early research (Phase 1)WithdrawnNCT00560495
What this trial is testing

Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT00655161
What this trial is testing

A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant S. Cerevisiae Expressing Mutant Ras Protein, as Consolidation Therapy Following Curative Treatment for Stage I-III Non-Small Cell Lung Cancer (NSCLC) With Tumor Sequence Confirmation of K-ras Mutation

Who this might be right for
NSCLC
GlobeImmune 24
Not applicableLooking for participantsNCT07316062
What this trial is testing

A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China

Who this might be right for
Non-Small-Cell Lung
AstraZeneca 3,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04716946
What this trial is testing

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

Who this might be right for
NSCLCNon-small Cell Lung CancerLung Cancer+5 more
Memorial Sloan Kettering Cancer Center 13
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Testing effectiveness (Phase 2)Study completedNCT01166204
What this trial is testing

Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD)

Who this might be right for
Stage I-III Non-small Cell Lung Cancer
Maastricht Radiation Oncology 300
Not applicableStudy completedNCT00905086
What this trial is testing

Psychosocial Adjustment After Radiation Therapy in Patients With Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+3 more
Case Comprehensive Cancer Center 80
Testing effectiveness (Phase 2)UnknownNCT01218594
What this trial is testing

Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 50
Early research (Phase 1)Ended earlyNCT00288054
What this trial is testing

S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 24
Large-scale testing (Phase 3)Looking for participantsNCT02468024
What this trial is testing

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
University of Texas Southwestern Medical Center 272
Large-scale testing (Phase 3)Not Yet RecruitingNCT06955325
What this trial is testing

Umbrella Trial of Adjuvant Therapy in Completely Resected High-risk Stage IA-IB NSCLC: Focus on Driver Mutations

Who this might be right for
Non-Small Cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University 270
Testing effectiveness (Phase 2)Looking for participantsNCT04933903
What this trial is testing

BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

Who this might be right for
Non Small Cell Lung Cancer
Brown University 25
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Early research (Phase 1)Study completedNCT00002625
What this trial is testing

Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Esophageal CancerLung CancerLymphoma
National Cancer Institute (NCI) 5
Early research (Phase 1)Ended earlyNCT02252796
What this trial is testing

Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
West Virginia University 1
Testing effectiveness (Phase 2)Looking for participantsNCT07122687
What this trial is testing

IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 170
Next Page